School of Population Health, The University of Auckland, Auckland, New Zealand.
Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
J Steroid Biochem Mol Biol. 2020 Jul;201:105687. doi: 10.1016/j.jsbmb.2020.105687. Epub 2020 Apr 30.
The increasing use of vitamin D supplements has stimulated interest in identifying factors that may modify the effect of supplementation on circulating 25-hydroxyvitamin D (25(OH)D) concentrations. Such information is of potential interest to researchers, clinicians and patients when deciding on bolus dose of vitamin D supplementation. We carried out a large randomized controlled trial of 5110 adults aged 50-84 years, of European/Other (84%), Polynesian (11%) and Asian (5%) ethnicity, to whom we gave a standard dose of vitamin D supplements (200,000 IU initially, then 100,000 IU monthly) which was taken with high adherence. All participants provided a baseline blood sample, and follow-up blood samples were collected at 6 months and annually for 3 years in a random sample of 441 participants, and also at 2 years in 413 participants enrolled in a bone density sub-study. Serum 25(OH)D was measured by LC/MSMS. Mixed model analyses were carried out on all 854 participants providing follow-up blood samples in multivariable models that included age, sex, ethnicity, body mass index (kg/m), tobacco smoking, alcohol intake, physical activity, sun exposure, season, medical prescription of high-dose vitamin D (Cal.D.Forte tablets), asthma/COPD and the study treatment (vitamin D or placebo). The adjusted mean difference in 25(OH)D in the follow-up points between vitamin D supplementation and placebo groups was inversely related (all p for interaction <0.05) to baseline 25(OH)D, BMI, and hours of sun exposure, and higher in females, elders, and those with high frequency of alcohol, medical prescription of vitamin D, and asthma/COPD. The mean difference was not significantly related to ethnicity (p = 0.12), tobacco (p = 0.34), and vigorous activity (p = 0.33). In summary, these data show that vitamin D status, BMI, sun exposure hours, sex and asthma/COPD modify the 25(OH)D response to vitamin D supplementation. By contrast, ethnicity, tobacco smoking, and vigorous activity do not.
维生素 D 补充剂的使用日益增加,这激发了人们对确定可能影响补充剂对循环 25-羟维生素 D(25(OH)D)浓度影响的因素的兴趣。在决定给予维生素 D 补充剂的冲击剂量时,此类信息对研究人员、临床医生和患者具有潜在意义。我们对 5110 名年龄在 50-84 岁的欧洲/其他族裔(84%)、波利尼西亚族裔(11%)和亚裔(5%)成年人进行了一项大型随机对照试验,给予他们标准剂量的维生素 D 补充剂(最初 20 万 IU,然后每月 10 万 IU),并确保他们高剂量服用。所有参与者均提供了基线血样,然后在 441 名随机参与者中每 6 个月和每年进行一次随访血样采集,在 413 名入组骨密度子研究的参与者中每 2 年进行一次。通过 LC/MSMS 测量血清 25(OH)D。在多变量模型中对所有提供随访血样的 854 名参与者进行混合模型分析,模型中包含年龄、性别、种族、体重指数(kg/m)、吸烟状况、饮酒量、身体活动、日照时间、季节、高剂量维生素 D(Cal.D.Forte 片剂)的处方、哮喘/COPD 和研究治疗(维生素 D 或安慰剂)。在随访点,维生素 D 补充组与安慰剂组的 25(OH)D 差值的调整均值与基线 25(OH)D、BMI 和日照时间呈负相关(交互作用的所有 p 值均<0.05),与女性、老年人、饮酒频率高、维生素 D 处方、哮喘/COPD 的参与者相关。差异均值与种族(p=0.12)、吸烟(p=0.34)和剧烈活动(p=0.33)均无显著相关性。总之,这些数据表明,维生素 D 状态、BMI、日照时间、性别和哮喘/COPD 会影响维生素 D 补充对 25(OH)D 的反应。相比之下,种族、吸烟和剧烈活动不会。